help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mawer, E. B.
Right arrow Articles by Knutson, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mawer, E. B.
Right arrow Articles by Knutson, J. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PARATHYROID HORMONE
*VITAMIN D2
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 6 2156-2166
Copyright © 1998 by The Endocrine Society


Original Studies

Unique 24-Hydroxylated Metabolites Represent a Significant Pathway of Metabolism of Vitamin D2 in Humans: 24-Hydroxyvitamin D2 and 1,24-Dihydroxyvitamin D2 Detectable in Human Serum1

E. Barbara Mawer, Glenville Jones, Michael Davies, Pamela E. Still, Valarie Byford, Neil J. Schroeder, Hugh L. J. Makin, Charles W. Bishop and Joyce C. Knutson

University Department of Medicine, Manchester Royal Infirmary, (E.B.M., M.D., P.E.S.), Manchester; and the Department of Clinical Biochemistry, St. Bartholomew’s and the Royal London School of Medicine and Dentistry (H.L.J.M., N.J.S.), London, United Kingdom; the Department of Biochemistry, Queen’s University (G.J., V.B.), Kingston, Ontario, Canada; and Bone Care International (C.W.B., J.C.K.), Madison, Wisconsin 53713

Address all correspondence and requests for reprints to: Prof. E. B. Mawer, Department of Medicine, Manchester Royal Infirmary, Manchester, United Kingdom M13 9WL.

We have produced evidence for a new metabolic pathway for vitamin D2 in humans involving the production of 24-hydroxyvitamin D2 (24OHD2) and 1,24-dihydroxyvitamin D2 [1,24-(OH)2D2]. These metabolites were produced after either a single large dose (106 IU) of vitamin D2 or repeated daily doses between 103 and 5 x 104 IU. We developed assay systems for the metabolites in human serum and showed that in some chronically treated patients, the concentration of 1,24-(OH)2D2 equalled that of 1,25-(OH)2D2 at about 100 pmol/L. The metabolites were identified by high performance liquid chromatography with diode array spectrophotometry for 24OHD2 and by high resolution gas chromatography-mass spectrometry for 1,24-(OH)2D2. We show that 1,24-(OH)2D2 synthesis can be stimulated by PTH, indicating a renal origin for this metabolite and postulate that it is formed from 24OHD2, which may be synthesized in liver. We conclude from this study that vitamin D2 gives rise to two biologically active products, 1,24-(OH)2D2 and 1,25-(OH)2D2, and that 1,24-(OH)2D2 could be an attractive naturally occurring analog of 1,25-(OH)2D3 for clinical use.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
K. J. Martin and E. A. Gonzalez
Metabolic Bone Disease in Chronic Kidney Disease
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. A Houghton and R. Vieth
The case against ergocalciferol (vitamin D2) as a vitamin supplement.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 694 - 697.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Z. Maunsell, D. J. Wright, and S. J. Rainbow
Routine Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of the 25-Hydroxy Metabolites of Vitamins D2 and D3
Clin. Chem., September 1, 2005; 51(9): 1683 - 1690.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. P. Gupta, Y. A. He, K. S. Patrick, J. R. Halpert, and N. H. Bell
CYP3A4 Is a Vitamin D-24- and 25-Hydroxylase: Analysis of Structure Function by Site-Directed Mutagenesis
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1210 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. A. Upton, J. C. Knutson, C. W. Bishop, and L. W. LeVan
Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone
Nephrol. Dial. Transplant., April 1, 2003; 18(4): 750 - 758.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Vieth, P.-C. R Chan, and G. D MacFarlane
Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level
Am. J. Clinical Nutrition, February 1, 2001; 73(2): 288 - 294.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. J. Schroeder and J. Cunningham
What's new in vitamin D for the nephrologist?
Nephrol. Dial. Transplant., April 1, 2000; 15(4): 460 - 466.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society